Novel pharmaceutical formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/66 (2006.01) A61K 9/127 (2006.01)

Patent

CA 2211409

The invention relates to a pharmaceutical composition for topical administration comprising a combination of foscarnet and an antiinflammatory glucocorticoid, in admixture with a carrier based on galactolipids and a polar solvent. The pharmaceutical composition can be used in a prophylactic and/or curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of said pharmaceutical composition in the manufacture of a medicament for said prophylactic or curative treatment.

La présente invention concerne une composition pharmaceutique pour administration locale comprenant une association de foscarnet et d'un glucocorticoïde anti-inflammatoire, avec comme excipient des galactolipides et un solvant polaire. Cette composition pharmaceutique est utilisable pour le traitement prophylactique et/ou curatif des infections par le virus de l'herpès chez les mammifères y compris l'homme. L'invention concerne également l'utilisation de ladite composition pharmaceutique pour la fabrication d'un médicament destiné audit traitement prophylactique et/ou curatif.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Novel pharmaceutical formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel pharmaceutical formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel pharmaceutical formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1910438

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.